

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | leukocyte migration involved in inflammatory response (GO:0002523) | 8.82598507 |
| 2 | leukocyte aggregation (GO:0070486) | 8.60756621 |
| 3 | response to fungus (GO:0009620) | 8.40623934 |
| 4 | killing of cells of other organism (GO:0031640) | 7.75770451 |
| 5 | disruption of cells of other organism (GO:0044364) | 7.75770451 |
| 6 | sequestering of metal ion (GO:0051238) | 7.30364996 |
| 7 | neutrophil mediated immunity (GO:0002446) | 6.86713716 |
| 8 | response to peptidoglycan (GO:0032494) | 6.78321500 |
| 9 | respiratory burst (GO:0045730) | 6.20490504 |
| 10 | pentose-phosphate shunt (GO:0006098) | 5.67206016 |
| 11 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 5.47460804 |
| 12 | regulation of growth of symbiont in host (GO:0044126) | 5.47460804 |
| 13 | negative regulation of growth of symbiont in host (GO:0044130) | 5.47460804 |
| 14 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 5.47460804 |
| 15 | negative regulation of phagocytosis (GO:0050765) | 5.45712046 |
| 16 | reactive oxygen species biosynthetic process (GO:1903409) | 5.36433592 |
| 17 | myeloid leukocyte mediated immunity (GO:0002444) | 5.27264833 |
| 18 | NADPH regeneration (GO:0006740) | 5.19644066 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 5.08320634 |
| 20 | negative regulation of interleukin-8 production (GO:0032717) | 5.05689584 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96551402 |
| 22 | microglial cell activation (GO:0001774) | 4.82890467 |
| 23 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.73496214 |
| 24 | cellular extravasation (GO:0045123) | 4.66927755 |
| 25 | chronic inflammatory response (GO:0002544) | 4.60231238 |
| 26 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.42769631 |
| 27 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.33674749 |
| 28 | cell killing (GO:0001906) | 4.21945871 |
| 29 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.19400629 |
| 30 | neutrophil activation (GO:0042119) | 4.15880644 |
| 31 | superoxide anion generation (GO:0042554) | 4.11805592 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.09460218 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.09460218 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 4.09460218 |
| 35 | positive regulation by symbiont of host defense response (GO:0052509) | 4.09460218 |
| 36 | modulation by symbiont of host defense response (GO:0052031) | 4.09460218 |
| 37 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.09460218 |
| 38 | leukocyte mediated cytotoxicity (GO:0001909) | 4.08119701 |
| 39 | regulation of chemokine biosynthetic process (GO:0045073) | 4.06201264 |
| 40 | leukotriene biosynthetic process (GO:0019370) | 4.00716343 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.99124508 |
| 42 | leukotriene metabolic process (GO:0006691) | 3.97445487 |
| 43 | detection of bacterium (GO:0016045) | 3.97229235 |
| 44 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.95829370 |
| 45 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.91197577 |
| 46 | pentose metabolic process (GO:0019321) | 3.91006012 |
| 47 | detection of external biotic stimulus (GO:0098581) | 3.88023535 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 3.84003433 |
| 49 | glucose catabolic process (GO:0006007) | 3.83495027 |
| 50 | detection of other organism (GO:0098543) | 3.78305002 |
| 51 | macrophage activation (GO:0042116) | 3.76744868 |
| 52 | neutrophil chemotaxis (GO:0030593) | 3.76593383 |
| 53 | granulocyte activation (GO:0036230) | 3.75553799 |
| 54 | neutrophil migration (GO:1990266) | 3.66081071 |
| 55 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.64422791 |
| 56 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.52489563 |
| 57 | detection of biotic stimulus (GO:0009595) | 3.46209019 |
| 58 | regulation of leukocyte degranulation (GO:0043300) | 3.44616740 |
| 59 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.40559469 |
| 60 | negative regulation of interleukin-6 production (GO:0032715) | 3.37654040 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.35346419 |
| 62 | regulation of gamma-delta T cell activation (GO:0046643) | 3.34800363 |
| 63 | negative regulation of cell killing (GO:0031342) | 3.34726637 |
| 64 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.34726637 |
| 65 | granulocyte migration (GO:0097530) | 3.29640800 |
| 66 | oxygen transport (GO:0015671) | 3.25661093 |
| 67 | phagosome maturation (GO:0090382) | 3.18634325 |
| 68 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.17629121 |
| 69 | regulation of mast cell activation (GO:0033003) | 3.16008316 |
| 70 | actin nucleation (GO:0045010) | 3.15301335 |
| 71 | NADP metabolic process (GO:0006739) | 3.14160050 |
| 72 | interaction with symbiont (GO:0051702) | 3.13162495 |
| 73 | glucose 6-phosphate metabolic process (GO:0051156) | 3.12228358 |
| 74 | granulocyte chemotaxis (GO:0071621) | 3.11912312 |
| 75 | regulation of mast cell degranulation (GO:0043304) | 3.09625489 |
| 76 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.08234131 |
| 77 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.06087343 |
| 78 | regulation of regulated secretory pathway (GO:1903305) | 3.05597824 |
| 79 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.05168659 |
| 80 | modification by host of symbiont morphology or physiology (GO:0051851) | 3.05141537 |
| 81 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.03874777 |
| 82 | leukocyte cell-cell adhesion (GO:0007159) | 3.02877331 |
| 83 | B cell receptor signaling pathway (GO:0050853) | 2.99415818 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.99146328 |
| 85 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.96095938 |
| 86 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.94718856 |
| 87 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94718856 |
| 88 | response to muramyl dipeptide (GO:0032495) | 2.93755726 |
| 89 | positive regulation of mast cell activation (GO:0033005) | 2.92581705 |
| 90 | response to host immune response (GO:0052572) | 2.91765802 |
| 91 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91765802 |
| 92 | mannose metabolic process (GO:0006013) | 2.91272640 |
| 93 | innate immune response in mucosa (GO:0002227) | 2.89771560 |
| 94 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.89418798 |
| 95 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.88277655 |
| 96 | detection of molecule of bacterial origin (GO:0032490) | 2.87955296 |
| 97 | cellular response to zinc ion (GO:0071294) | 2.86087899 |
| 98 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.85859825 |
| 99 | defense response to Gram-positive bacterium (GO:0050830) | 2.85214455 |
| 100 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.85048080 |
| 101 | positive regulation of lamellipodium assembly (GO:0010592) | 2.85032588 |
| 102 | positive regulation of B cell differentiation (GO:0045579) | 2.84452772 |
| 103 | positive regulation of regulated secretory pathway (GO:1903307) | 2.81103834 |
| 104 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.78684240 |
| 105 | antibacterial humoral response (GO:0019731) | 2.77396259 |
| 106 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.77379450 |
| 107 | imidazole-containing compound metabolic process (GO:0052803) | 2.75560928 |
| 108 | antimicrobial humoral response (GO:0019730) | 2.73610020 |
| 109 | response to zinc ion (GO:0010043) | 2.73071160 |
| 110 | negative regulation of interleukin-12 production (GO:0032695) | 2.70878983 |
| 111 | * macrophage differentiation (GO:0030225) | 2.68897643 |
| 112 | regulation of phagocytosis (GO:0050764) | 2.66436326 |
| 113 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.64464203 |
| 114 | positive regulation of mast cell degranulation (GO:0043306) | 2.64464203 |
| 115 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.62360063 |
| 116 | leukocyte degranulation (GO:0043299) | 2.59870080 |
| 117 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.59773104 |
| 118 | response to host (GO:0075136) | 2.59773104 |
| 119 | response to host defenses (GO:0052200) | 2.59773104 |
| 120 | mucosal immune response (GO:0002385) | 2.58171532 |
| 121 | regulation of hypersensitivity (GO:0002883) | 2.58055341 |
| 122 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.57963383 |
| 123 | hydrogen peroxide metabolic process (GO:0042743) | 2.57781818 |
| 124 | DNA unwinding involved in DNA replication (GO:0006268) | 2.51692881 |
| 125 | immunoglobulin mediated immune response (GO:0016064) | 2.51508896 |
| 126 | regulation of B cell differentiation (GO:0045577) | 2.46572823 |
| 127 | * defense response to bacterium (GO:0042742) | 2.45592269 |
| 128 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.45261171 |
| 129 | organ or tissue specific immune response (GO:0002251) | 2.43068806 |
| 130 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.42233056 |
| 131 | lipoxygenase pathway (GO:0019372) | 2.42131674 |
| 132 | homotypic cell-cell adhesion (GO:0034109) | 2.40784683 |
| 133 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 10.1064993 |
| 134 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 10.1064993 |
| 135 | defense response to fungus (GO:0050832) | 10.0379074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.64251079 |
| 2 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.26537380 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.75122639 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.57916915 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.34083577 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.29833098 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.01435077 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.89666389 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.87514891 |
| 10 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.80697802 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.58741949 |
| 12 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.55333072 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.50056031 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46774413 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44270892 |
| 16 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42510156 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.40458677 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.34106125 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.33229163 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.29138977 |
| 21 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.26210461 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16997006 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08940135 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04197367 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.01171164 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.96545067 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.96442008 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.91938350 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88428359 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86851511 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.85912796 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84796891 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79113977 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75705276 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.75330163 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74455104 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.72855576 |
| 38 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69474681 |
| 39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69411516 |
| 40 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.67959449 |
| 41 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65049703 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56902046 |
| 43 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54766975 |
| 44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54394933 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.53619571 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53354861 |
| 47 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.52596912 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51276670 |
| 49 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50904779 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49272369 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47927801 |
| 52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46444457 |
| 53 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44261559 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43515016 |
| 55 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42723483 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39551107 |
| 57 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38879827 |
| 58 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.38794420 |
| 59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38292452 |
| 60 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37325208 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.36437274 |
| 62 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.36111523 |
| 63 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.33527134 |
| 64 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32695320 |
| 65 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.32177716 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32056833 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30908575 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29935740 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28264123 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27901877 |
| 71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27074405 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25692344 |
| 73 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.25138063 |
| 74 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24375733 |
| 75 | P68_20966046_ChIP-Seq_HELA_Human | 1.23229669 |
| 76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22872778 |
| 77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22451398 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21973162 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20887210 |
| 80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.20743908 |
| 81 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20274799 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19593689 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18654342 |
| 84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18547770 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18381249 |
| 86 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17899959 |
| 87 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.16948942 |
| 88 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15318774 |
| 89 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15245997 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13882069 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 1.13873715 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13372680 |
| 93 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.10010706 |
| 94 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08617293 |
| 95 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08251250 |
| 96 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07523897 |
| 97 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06290915 |
| 98 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05607356 |
| 99 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05565932 |
| 100 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.05081542 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04443153 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03240086 |
| 103 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01808115 |
| 104 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01369659 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00660522 |
| 106 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98561525 |
| 107 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.98521547 |
| 108 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.96781388 |
| 109 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.96140218 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95657028 |
| 111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95464816 |
| 112 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94448637 |
| 113 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94301763 |
| 114 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.93873204 |
| 115 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93783955 |
| 116 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.93522259 |
| 117 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.93233493 |
| 118 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91368357 |
| 119 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91254431 |
| 120 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90619529 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90152877 |
| 122 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.89850641 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87570887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.63876936 |
| 2 | MP0009785_altered_susceptibility_to | 3.69722540 |
| 3 | MP0003183_abnormal_peptide_metabolism | 3.69698777 |
| 4 | * MP0002419_abnormal_innate_immunity | 3.34249056 |
| 5 | MP0005464_abnormal_platelet_physiology | 3.14983863 |
| 6 | * MP0005025_abnormal_response_to | 2.67979816 |
| 7 | * MP0003303_peritoneal_inflammation | 2.36336824 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.36307423 |
| 9 | MP0000465_gastrointestinal_hemorrhage | 2.36272025 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.28938812 |
| 11 | MP0003693_abnormal_embryo_hatching | 2.28817711 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.14302539 |
| 13 | MP0003656_abnormal_erythrocyte_physiolo | 2.13663598 |
| 14 | MP0009278_abnormal_bone_marrow | 2.11420043 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.09429109 |
| 16 | MP0005397_hematopoietic_system_phenotyp | 2.05983053 |
| 17 | MP0001545_abnormal_hematopoietic_system | 2.05983053 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.03159829 |
| 19 | MP0001853_heart_inflammation | 2.02516240 |
| 20 | * MP0001819_abnormal_immune_cell | 2.01143253 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.99456722 |
| 22 | MP0000685_abnormal_immune_system | 1.99100997 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.98452464 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.97404241 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.92271995 |
| 26 | MP0000343_altered_response_to | 1.92038136 |
| 27 | MP0004808_abnormal_hematopoietic_stem | 1.91786107 |
| 28 | MP0001800_abnormal_humoral_immune | 1.90765070 |
| 29 | * MP0001533_abnormal_skeleton_physiology | 1.88951899 |
| 30 | MP0004147_increased_porphyrin_level | 1.86176976 |
| 31 | * MP0001845_abnormal_inflammatory_respons | 1.84381035 |
| 32 | MP0003724_increased_susceptibility_to | 1.84177491 |
| 33 | MP0002723_abnormal_immune_serum | 1.84169730 |
| 34 | MP0008260_abnormal_autophagy | 1.77476324 |
| 35 | * MP0002398_abnormal_bone_marrow | 1.76835789 |
| 36 | * MP0002405_respiratory_system_inflammati | 1.76740578 |
| 37 | MP0005360_urolithiasis | 1.73577580 |
| 38 | MP0002132_abnormal_respiratory_system | 1.73568041 |
| 39 | MP0009840_abnormal_foam_cell | 1.72803766 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.69542756 |
| 41 | * MP0000716_abnormal_immune_system | 1.65828883 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.62830336 |
| 43 | MP0000858_altered_metastatic_potential | 1.57798138 |
| 44 | MP0008469_abnormal_protein_level | 1.57554083 |
| 45 | MP0003828_pulmonary_edema | 1.55307280 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.53881369 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.52592430 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.52494711 |
| 49 | * MP0002429_abnormal_blood_cell | 1.52300780 |
| 50 | MP0005451_abnormal_body_composition | 1.51187547 |
| 51 | MP0005671_abnormal_response_to | 1.50609717 |
| 52 | MP0001790_abnormal_immune_system | 1.48938235 |
| 53 | MP0005387_immune_system_phenotype | 1.48938235 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.47438968 |
| 55 | MP0010307_abnormal_tumor_latency | 1.47331006 |
| 56 | * MP0002722_abnormal_immune_system | 1.46680189 |
| 57 | MP0010094_abnormal_chromosome_stability | 1.43059377 |
| 58 | MP0002139_abnormal_hepatobiliary_system | 1.41209941 |
| 59 | MP0003111_abnormal_nucleus_morphology | 1.40721011 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.40235066 |
| 61 | MP0000490_abnormal_crypts_of | 1.36898090 |
| 62 | MP0003075_altered_response_to | 1.36175972 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 1.31801972 |
| 64 | MP0009764_decreased_sensitivity_to | 1.27454857 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.26799157 |
| 66 | MP0001873_stomach_inflammation | 1.26396740 |
| 67 | MP0003186_abnormal_redox_activity | 1.25910705 |
| 68 | MP0001764_abnormal_homeostasis | 1.25546569 |
| 69 | MP0005365_abnormal_bile_salt | 1.24737747 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.23574285 |
| 71 | MP0008057_abnormal_DNA_replication | 1.21874458 |
| 72 | * MP0010155_abnormal_intestine_physiology | 1.20853899 |
| 73 | MP0005085_abnormal_gallbladder_physiolo | 1.17231990 |
| 74 | MP0009763_increased_sensitivity_to | 1.13846458 |
| 75 | MP0005023_abnormal_wound_healing | 1.13784141 |
| 76 | MP0005076_abnormal_cell_differentiation | 1.12969025 |
| 77 | MP0002006_tumorigenesis | 1.11299511 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 1.08141958 |
| 79 | MP0003077_abnormal_cell_cycle | 1.08124308 |
| 80 | MP0005310_abnormal_salivary_gland | 1.07099691 |
| 81 | MP0004947_skin_inflammation | 1.04401867 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 1.00026468 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.99845688 |
| 84 | MP0005083_abnormal_biliary_tract | 0.98639610 |
| 85 | MP0002998_abnormal_bone_remodeling | 0.97796784 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.97674746 |
| 87 | MP0004883_abnormal_blood_vessel | 0.97272904 |
| 88 | MP0000609_abnormal_liver_physiology | 0.96743539 |
| 89 | MP0002009_preneoplasia | 0.96534549 |
| 90 | MP0000703_abnormal_thymus_morphology | 0.96443411 |
| 91 | MP0004381_abnormal_hair_follicle | 0.94511821 |
| 92 | MP0004957_abnormal_blastocyst_morpholog | 0.94110820 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.92055932 |
| 94 | * MP0001851_eye_inflammation | 0.91714007 |
| 95 | MP0002933_joint_inflammation | 0.91397920 |
| 96 | MP0003448_altered_tumor_morphology | 0.88967103 |
| 97 | MP0004130_abnormal_muscle_cell | 0.88895513 |
| 98 | MP0005164_abnormal_response_to | 0.87531943 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.86926313 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 0.85932311 |
| 101 | MP0002277_abnormal_respiratory_mucosa | 0.85023303 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81463683 |
| 103 | MP0003763_abnormal_thymus_physiology | 0.81176527 |
| 104 | MP0000598_abnormal_liver_morphology | 0.80814387 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80190069 |
| 106 | MP0008873_increased_physiological_sensi | 0.78520671 |
| 107 | * MP0005390_skeleton_phenotype | 0.77398851 |
| 108 | MP0005166_decreased_susceptibility_to | 0.76844664 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.76717605 |
| 110 | MP0000249_abnormal_blood_vessel | 0.76564461 |
| 111 | MP0003866_abnormal_defecation | 0.75722691 |
| 112 | MP0002089_abnormal_postnatal_growth/wei | 0.75477651 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.72842959 |
| 114 | MP0010352_gastrointestinal_tract_polyps | 0.71901576 |
| 115 | MP0003123_paternal_imprinting | 0.71561640 |
| 116 | MP0006082_CNS_inflammation | 0.69944178 |
| 117 | MP0000313_abnormal_cell_death | 0.69202805 |
| 118 | MP0000604_amyloidosis | 0.68623386 |
| 119 | MP0008874_decreased_physiological_sensi | 0.67744509 |
| 120 | * MP0001663_abnormal_digestive_system | 0.63558597 |
| 121 | MP0003690_abnormal_glial_cell | 0.63471727 |
| 122 | MP0006036_abnormal_mitochondrial_physio | 0.61406570 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.61224320 |
| 124 | * MP0003795_abnormal_bone_structure | 0.60501887 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.58010314 |
| 126 | MP0006035_abnormal_mitochondrial_morpho | 0.55111066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 8.53147117 |
| 2 | Recurrent abscess formation (HP:0002722) | 8.12449182 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.95427197 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 7.31878456 |
| 5 | Chronic obstructive pulmonary disease (HP:0006510) | 6.02634971 |
| 6 | Obstructive lung disease (HP:0006536) | 6.02634971 |
| 7 | Hypochromic microcytic anemia (HP:0004840) | 5.03061805 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.85888908 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.85633828 |
| 10 | Recurrent skin infections (HP:0001581) | 4.55698618 |
| 11 | Gingivitis (HP:0000230) | 4.55561623 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.33658834 |
| 13 | Cellulitis (HP:0100658) | 4.06378217 |
| 14 | Urticaria (HP:0001025) | 3.98564062 |
| 15 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.90467015 |
| 16 | Meningitis (HP:0001287) | 3.88601719 |
| 17 | Thrombocytosis (HP:0001894) | 3.73182653 |
| 18 | Stomatitis (HP:0010280) | 3.68970967 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.42373643 |
| 20 | Papilledema (HP:0001085) | 3.40531153 |
| 21 | Loss of speech (HP:0002371) | 3.33166277 |
| 22 | Petechiae (HP:0000967) | 3.29186156 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.25048930 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.23701314 |
| 25 | Optic neuritis (HP:0100653) | 3.23701314 |
| 26 | Microcytic anemia (HP:0001935) | 3.17400875 |
| 27 | Periodontitis (HP:0000704) | 3.12497482 |
| 28 | Myositis (HP:0100614) | 3.02914074 |
| 29 | Abnormal platelet volume (HP:0011876) | 2.99525467 |
| 30 | Chest pain (HP:0100749) | 2.85394869 |
| 31 | Panhypogammaglobulinemia (HP:0003139) | 2.83181076 |
| 32 | Keratoconjunctivitis sicca (HP:0001097) | 2.82899297 |
| 33 | IgM deficiency (HP:0002850) | 2.82677690 |
| 34 | Epistaxis (HP:0000421) | 2.82116928 |
| 35 | Abnormal platelet function (HP:0011869) | 2.78365549 |
| 36 | Impaired platelet aggregation (HP:0003540) | 2.78365549 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.77018584 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.77018584 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.77018584 |
| 40 | Osteomyelitis (HP:0002754) | 2.76387861 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.75572391 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.75206293 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.75206293 |
| 44 | Increased serum ferritin (HP:0003281) | 2.69314795 |
| 45 | Recurrent viral infections (HP:0004429) | 2.68894804 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.61194224 |
| 47 | Chronic otitis media (HP:0000389) | 2.60310289 |
| 48 | Gingival bleeding (HP:0000225) | 2.56488964 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.56148732 |
| 50 | Abnormality of the prostate (HP:0008775) | 2.53332483 |
| 51 | Increased mean platelet volume (HP:0011877) | 2.52570559 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.51400263 |
| 53 | Sepsis (HP:0100806) | 2.50900441 |
| 54 | Eosinophilia (HP:0001880) | 2.50869650 |
| 55 | Granulocytopenia (HP:0001913) | 2.48155269 |
| 56 | Leukocytosis (HP:0001974) | 2.45368519 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43483224 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43483224 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43483224 |
| 60 | Hypergammaglobulinemia (HP:0010702) | 2.41390216 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.39841574 |
| 62 | Agammaglobulinemia (HP:0004432) | 2.39211637 |
| 63 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.38223990 |
| 64 | Skin ulcer (HP:0200042) | 2.36798474 |
| 65 | Joint hemorrhage (HP:0005261) | 2.31164718 |
| 66 | Vasculitis (HP:0002633) | 2.29868758 |
| 67 | Thoracic kyphosis (HP:0002942) | 2.28785324 |
| 68 | Recurrent pneumonia (HP:0006532) | 2.28340321 |
| 69 | Hemoptysis (HP:0002105) | 2.28073441 |
| 70 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.26749930 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.25819487 |
| 72 | B lymphocytopenia (HP:0010976) | 2.22805789 |
| 73 | Abnormality of B cell number (HP:0010975) | 2.22805789 |
| 74 | Reticulocytopenia (HP:0001896) | 2.22464026 |
| 75 | Abnormality of the common coagulation pathway (HP:0010990) | 2.20769701 |
| 76 | Episodic fever (HP:0001954) | 2.20726263 |
| 77 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.18585345 |
| 78 | Slow saccadic eye movements (HP:0000514) | 2.17403350 |
| 79 | Abnormality of the thoracic spine (HP:0100711) | 2.16277251 |
| 80 | Cutaneous melanoma (HP:0012056) | 2.13667722 |
| 81 | Menorrhagia (HP:0000132) | 2.13209625 |
| 82 | Deep venous thrombosis (HP:0002625) | 2.13041116 |
| 83 | Polycythemia (HP:0001901) | 2.11637399 |
| 84 | Amyloidosis (HP:0011034) | 2.11616032 |
| 85 | Abnormality of the fingertips (HP:0001211) | 2.10364828 |
| 86 | Interstitial pulmonary disease (HP:0006530) | 2.08062877 |
| 87 | Anorexia (HP:0002039) | 2.07391848 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 2.06033095 |
| 89 | Acute lymphatic leukemia (HP:0006721) | 2.05823306 |
| 90 | Pulmonary embolism (HP:0002204) | 2.04783262 |
| 91 | Hypermelanotic macule (HP:0001034) | 2.03671097 |
| 92 | Neutropenia (HP:0001875) | 2.02925115 |
| 93 | Abnormality of T cells (HP:0002843) | 2.02699613 |
| 94 | Asymmetric septal hypertrophy (HP:0001670) | 2.02193117 |
| 95 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.01455636 |
| 96 | Thrombophlebitis (HP:0004418) | 2.01391597 |
| 97 | Pustule (HP:0200039) | 2.01360370 |
| 98 | Hypertriglyceridemia (HP:0002155) | 2.00860118 |
| 99 | Colitis (HP:0002583) | 2.00733404 |
| 100 | Disinhibition (HP:0000734) | 1.99895684 |
| 101 | Cutaneous photosensitivity (HP:0000992) | 1.98000450 |
| 102 | Hepatosplenomegaly (HP:0001433) | 1.96348050 |
| 103 | Spontaneous hematomas (HP:0007420) | 1.96027854 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 1.95495377 |
| 105 | Hypochromic anemia (HP:0001931) | 1.94129676 |
| 106 | Gastrointestinal infarctions (HP:0005244) | 1.91504277 |
| 107 | Abnormality of the lumbar spine (HP:0100712) | 1.91480547 |
| 108 | Gangrene (HP:0100758) | 1.89875924 |
| 109 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89363940 |
| 110 | Aplastic anemia (HP:0001915) | 1.88741954 |
| 111 | Myelodysplasia (HP:0002863) | 1.88410357 |
| 112 | Cheilitis (HP:0100825) | 1.86939334 |
| 113 | Dysostosis multiplex (HP:0000943) | 1.86614521 |
| 114 | Abnormality of eosinophils (HP:0001879) | 1.86595413 |
| 115 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.83810039 |
| 116 | Purpura (HP:0000979) | 1.82882350 |
| 117 | Orchitis (HP:0100796) | 1.82613261 |
| 118 | Inflammation of the large intestine (HP:0002037) | 1.80424999 |
| 119 | Poikiloderma (HP:0001029) | 1.80424681 |
| 120 | Prolonged partial thromboplastin time (HP:0003645) | 1.79861165 |
| 121 | Gastrointestinal inflammation (HP:0004386) | 1.79704087 |
| 122 | Arterial thrombosis (HP:0004420) | 1.79132624 |
| 123 | Increased IgE level (HP:0003212) | 1.79106068 |
| 124 | Abnormality of the pleura (HP:0002103) | 1.77295361 |
| 125 | Lymphopenia (HP:0001888) | 1.75774341 |
| 126 | Encephalitis (HP:0002383) | 1.75389876 |
| 127 | Skin rash (HP:0000988) | 1.75269226 |
| 128 | Abnormal foot bone ossification (HP:0010675) | 1.71373680 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.70271104 |
| 130 | Autoimmune thrombocytopenia (HP:0001973) | 1.69999618 |
| 131 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.69638272 |
| 132 | Mucopolysacchariduria (HP:0008155) | 1.69638272 |
| 133 | Increased density of long bones (HP:0006392) | 1.67817976 |
| 134 | Pulmonary infiltrates (HP:0002113) | 1.66411631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 5.14653645 |
| 2 | TESK2 | 3.27350156 |
| 3 | BLK | 3.17980049 |
| 4 | FES | 2.86012703 |
| 5 | EPHB1 | 2.66539212 |
| 6 | GRK6 | 2.58860125 |
| 7 | ERN1 | 2.42873476 |
| 8 | BTK | 2.41157564 |
| 9 | MAP4K1 | 2.40486246 |
| 10 | PRPF4B | 2.35858433 |
| 11 | MAP2K3 | 2.26860157 |
| 12 | TESK1 | 2.25488499 |
| 13 | TRPM7 | 2.23212422 |
| 14 | RIPK4 | 2.21563660 |
| 15 | PKN2 | 2.08056599 |
| 16 | TAOK3 | 2.07470216 |
| 17 | MAP3K12 | 2.06404881 |
| 18 | WEE1 | 1.84887562 |
| 19 | TEC | 1.80132751 |
| 20 | TRIB3 | 1.76298139 |
| 21 | CLK1 | 1.72881308 |
| 22 | STK10 | 1.66623348 |
| 23 | CSK | 1.65530569 |
| 24 | CDK12 | 1.60447269 |
| 25 | EEF2K | 1.54831548 |
| 26 | NEK2 | 1.51022213 |
| 27 | PAK4 | 1.50008420 |
| 28 | TTN | 1.47792267 |
| 29 | ZAP70 | 1.46761161 |
| 30 | LRRK2 | 1.34395860 |
| 31 | SYK | 1.30381026 |
| 32 | HCK | 1.30253275 |
| 33 | CDC7 | 1.29531145 |
| 34 | TAOK2 | 1.29087761 |
| 35 | SMG1 | 1.28034418 |
| 36 | ERBB3 | 1.17619581 |
| 37 | MAP2K4 | 1.14465087 |
| 38 | MAP3K11 | 1.12150813 |
| 39 | STK16 | 1.11399843 |
| 40 | ALK | 1.10822142 |
| 41 | LIMK1 | 1.09880827 |
| 42 | TYK2 | 1.07557928 |
| 43 | PIM2 | 1.07427921 |
| 44 | PIM1 | 1.06064935 |
| 45 | KDR | 1.05945271 |
| 46 | TGFBR2 | 1.05346617 |
| 47 | LATS1 | 1.04532697 |
| 48 | MAP3K8 | 1.02601861 |
| 49 | IRAK2 | 1.01973256 |
| 50 | IRAK3 | 1.01323362 |
| 51 | CSF1R | 0.98463905 |
| 52 | CDK19 | 0.94493486 |
| 53 | EIF2AK3 | 0.92368495 |
| 54 | KIT | 0.91512731 |
| 55 | BRSK2 | 0.91358872 |
| 56 | CAMK1D | 0.91003121 |
| 57 | FGR | 0.90647767 |
| 58 | PTK6 | 0.90302405 |
| 59 | FLT3 | 0.89641029 |
| 60 | PDPK1 | 0.88507011 |
| 61 | PRKG2 | 0.88430276 |
| 62 | IRAK1 | 0.87427411 |
| 63 | TAOK1 | 0.86903978 |
| 64 | LYN | 0.86476200 |
| 65 | PDK1 | 0.84260414 |
| 66 | MAP3K6 | 0.83849923 |
| 67 | MAP3K13 | 0.81775766 |
| 68 | BUB1 | 0.78183942 |
| 69 | IKBKB | 0.77689197 |
| 70 | STK4 | 0.77597144 |
| 71 | YES1 | 0.76513770 |
| 72 | TBK1 | 0.75516722 |
| 73 | RPS6KL1 | 0.75146537 |
| 74 | RPS6KC1 | 0.75146537 |
| 75 | SIK2 | 0.73960916 |
| 76 | RPS6KA6 | 0.73758554 |
| 77 | ITK | 0.73312082 |
| 78 | SCYL2 | 0.73123401 |
| 79 | TXK | 0.69904671 |
| 80 | NUAK1 | 0.69444002 |
| 81 | MARK3 | 0.69334405 |
| 82 | JAK2 | 0.68711668 |
| 83 | MAP3K14 | 0.65193237 |
| 84 | PIK3CG | 0.65077433 |
| 85 | LCK | 0.64473574 |
| 86 | RPS6KA2 | 0.64121430 |
| 87 | TNK2 | 0.61945149 |
| 88 | BCKDK | 0.61835746 |
| 89 | CDK7 | 0.61686301 |
| 90 | RAF1 | 0.60926927 |
| 91 | TLK1 | 0.60303828 |
| 92 | CDK4 | 0.58624377 |
| 93 | ATR | 0.57374739 |
| 94 | MAP2K6 | 0.56567769 |
| 95 | DAPK1 | 0.55622100 |
| 96 | GRK7 | 0.54795793 |
| 97 | ILK | 0.54249426 |
| 98 | MATK | 0.52716599 |
| 99 | MAPK12 | 0.52514832 |
| 100 | * MAPK4 | 0.51906365 |
| 101 | PRKCD | 0.50368880 |
| 102 | MAP3K3 | 0.49958109 |
| 103 | MAP2K2 | 0.49899247 |
| 104 | HIPK2 | 0.48712211 |
| 105 | MAPK11 | 0.48694180 |
| 106 | MARK2 | 0.47013936 |
| 107 | STK11 | 0.44274319 |
| 108 | RPS6KB2 | 0.43592566 |
| 109 | PRKD2 | 0.42883864 |
| 110 | ARAF | 0.42355365 |
| 111 | MAPKAPK2 | 0.40865975 |
| 112 | ACVR1B | 0.40787632 |
| 113 | NEK9 | 0.40219827 |
| 114 | CAMK1G | 0.39891662 |
| 115 | KSR2 | 0.39395471 |
| 116 | MAP3K10 | 0.39192107 |
| 117 | NEK1 | 0.38850280 |
| 118 | PRKCQ | 0.38498292 |
| 119 | RPS6KA4 | 0.38276095 |
| 120 | IKBKE | 0.38246940 |
| 121 | CDK6 | 0.38145633 |
| 122 | RET | 0.37714571 |
| 123 | CAMKK2 | 0.36016346 |
| 124 | MAP3K5 | 0.35265503 |
| 125 | JAK3 | 0.32824550 |
| 126 | FYN | 0.32147764 |
| 127 | MAPKAPK3 | 0.31337662 |
| 128 | CDK3 | 0.31184499 |
| 129 | CCNB1 | 0.30808422 |
| 130 | JAK1 | 0.30212199 |
| 131 | RPS6KA1 | 0.30134576 |
| 132 | PAK1 | 0.29742315 |
| 133 | MYLK | 0.29450360 |
| 134 | MAP3K1 | 0.29193900 |
| 135 | BMX | 0.29184056 |
| 136 | MAPK7 | 0.28231030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.19885987 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.53961939 |
| 3 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.88283056 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.76956959 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.74143739 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.50991390 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.27982811 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.02667017 |
| 9 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.96971392 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95750143 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.93794891 |
| 12 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.77364574 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67231627 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.64781926 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62908160 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.59117607 |
| 17 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.57347504 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.52430631 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47861146 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46297367 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.44925061 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.42648939 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.42416506 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.39015127 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38480899 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.37166081 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.36074964 |
| 28 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35596002 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.33611225 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32860072 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30905062 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29868233 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25732350 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24906950 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19870246 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18296909 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16144746 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.14137118 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13214211 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12548094 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08664949 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08060513 |
| 43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.07894726 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.06888054 |
| 45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.06695653 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06322318 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01345153 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01134224 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01023302 |
| 50 | Mismatch repair_Homo sapiens_hsa03430 | 1.00877519 |
| 51 | Base excision repair_Homo sapiens_hsa03410 | 0.99737607 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97631471 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.96393891 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94528189 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93593076 |
| 56 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93159860 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93032912 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 0.92827881 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90628372 |
| 60 | Cell cycle_Homo sapiens_hsa04110 | 0.89087073 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87842761 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87834671 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.87370324 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86166790 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84214029 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83347367 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81710000 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.81301245 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80860915 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.80126514 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.75974149 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75268978 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74889869 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74511099 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 0.74273444 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73786784 |
| 77 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.72179786 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71973324 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.71780778 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71747785 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71107935 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71064948 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69108017 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68471597 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.68279402 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67743350 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66422944 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65769068 |
| 89 | Ribosome_Homo sapiens_hsa03010 | 0.64493044 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64434392 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63899563 |
| 92 | Measles_Homo sapiens_hsa05162 | 0.62928759 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62312962 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.61707989 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61265704 |
| 96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61176608 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60606531 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60555217 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60503566 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59786164 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58619807 |
| 102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57754439 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57604885 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57602648 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57520707 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56692207 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.56225031 |
| 108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55437917 |
| 109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54908806 |
| 110 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54647403 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53972218 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53666591 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51986938 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51726725 |
| 115 | Influenza A_Homo sapiens_hsa05164 | 0.50712481 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.50520919 |
| 117 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49043848 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48972286 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48662831 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48332533 |
| 121 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.47218301 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.47086664 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46726368 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46680669 |
| 125 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46380044 |
| 126 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46372452 |
| 127 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46267024 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45394013 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44971879 |
| 130 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.44251413 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | 0.43844347 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43453879 |
| 133 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43072594 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.42438273 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42202217 |
| 136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42167176 |
| 137 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42098847 |
| 138 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41532982 |
| 139 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41138637 |
| 140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40099487 |
| 141 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37616499 |

